ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II Study of Nivolumab in Combination With Ipilimumab for Uveal Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01585194
Recruitment Status : Recruiting
First Posted : April 25, 2012
Last Update Posted : April 17, 2018
Sponsor:
Collaborators:
Bristol-Myers Squibb
National Cancer Institute (NCI)
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : November 2019
  Estimated Study Completion Date : November 2019